A HIV-1 Gp41 Peptide-Liposome Vaccine Elicits Neutralizing Epitope-Targeted Antibody Responses in Healthy Individuals

Nathan B. Erdmann, Wilton B. Williams, Stephen R. Walsh, Nicole Grunenberg, Paul T. Edlefsen, Paul A. Goepfert, Derek W. Cain, Kristen W. Cohen, Janine Maenza, Kenneth H. Mayer, Hong Van Tieu, Magdalena E. Sobieszczyk, Edith Swann, Huiyin Lu, Stephen C. De Rosa, Zachary Sagawa, M. Anthony Moody, Christopher B. Fox, Guido Ferrari, R.J. Edwards, Priyamvada Acharya, S. Munir Alam, Robert Parks, Margaret Barr, Georgia D. Tomaras, David C. Montefiori, Peter B. Gilbert, M. Juliana McElrath, Lawrence Corey, Barton F. Haynes, Lindsey R. Baden, NIAID HVTN 133 Study Group
doi: https://doi.org/10.1101/2024.03.15.24304305

Article Information

doi 
https://doi.org/10.1101/2024.03.15.24304305
History 
  • March 18, 2024.
Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.

Author Information

  1. Nathan B. Erdmann1,*,‡,
  2. Wilton B. Williams2,3,*,‡,
  3. Stephen R. Walsh6,7,*,‡,
  4. Nicole Grunenberg8,⊗,
  5. Paul T. Edlefsen8,
  6. Paul A. Goepfert1,
  7. Derek W. Cain2,4,
  8. Kristen W. Cohen8,§,
  9. Janine Maenza8,
  10. Kenneth H. Mayer7,9,
  11. Hong Van Tieu10,11,
  12. Magdalena E. Sobieszczyk11,
  13. Edith Swann12,
  14. Huiyin Lu8,
  15. Stephen C. De Rosa8,
  16. Zachary Sagawa13,
  17. M. Anthony Moody2,5,
  18. Christopher B. Fox13,
  19. Guido Ferrari2,3,
  20. R.J. Edwards2,4,
  21. Priyamvada Acharya2,3,
  22. S. Munir Alam2,4,
  23. Robert Parks2,
  24. Margaret Barr2,
  25. Georgia D. Tomaras2,3,
  26. David C. Montefiori2,3,
  27. Peter B. Gilbert8,
  28. M. Juliana McElrath8,
  29. Lawrence Corey8,
  30. Barton F. Haynes2,4,,‡,
  31. Lindsey R. Baden6,7,,‡,
  32. NIAID HVTN 133 Study Group
  1. 1University of Alabama at Birmingham, Birmingham, AL
  2. 2Duke Human Vaccine Institute, Duke University, Durham, NC
  3. 3Department of Surgery, Duke University School of Medicine, Durham, NC
  4. 4Department of Medicine, Duke University School of Medicine, Durham, NC
  5. 5Department of Pediatrics, Duke University School of Medicine, Durham, NC
  6. 6Division of Infectious Diseases, Brigham and Women’s Hospital, Boston, MA
  7. 7Harvard Medical School, Boston, MA
  8. 8Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA
  9. 9Fenway Institute, Boston, MA
  10. 10New York Blood Center, New York, NY
  11. 11Columbia University, New York, NY
  12. 12Division of AIDS, National Institute of Allergy and Immunology, Bethesda, MD
  13. 13Access to Advanced Health Institute, Seattle, WA
  1. ↵‡Corresponding Authors: Stephen Walsh, MD – swalsh{at}bwh.harvard.edu; Nathaniel Erdmann, MD – nberdmann{at}uabmc.edu; Wilton Williams, PhD – wilton.williams{at}duke.edu; Barton Haynes, MD – barton.haynes{at}duke.edu; Lindsey Baden, MD – lbaden{at}bwh.harvard.edu

  1. ↵* These authors contributed equally.

  2. ↵ These authors contributed equally.

  • ↵⊗ PATH, Seattle, WA

  • ↵§ ModernaTx, Cambridge, MA

Back to top
Posted March 18, 2024.
Download PDF

Supplementary Material

Data/Code
Email
A HIV-1 Gp41 Peptide-Liposome Vaccine Elicits Neutralizing Epitope-Targeted Antibody Responses in Healthy Individuals
Nathan B. Erdmann, Wilton B. Williams, Stephen R. Walsh, Nicole Grunenberg, Paul T. Edlefsen, Paul A. Goepfert, Derek W. Cain, Kristen W. Cohen, Janine Maenza, Kenneth H. Mayer, Hong Van Tieu, Magdalena E. Sobieszczyk, Edith Swann, Huiyin Lu, Stephen C. De Rosa, Zachary Sagawa, M. Anthony Moody, Christopher B. Fox, Guido Ferrari, R.J. Edwards, Priyamvada Acharya, S. Munir Alam, Robert Parks, Margaret Barr, Georgia D. Tomaras, David C. Montefiori, Peter B. Gilbert, M. Juliana McElrath, Lawrence Corey, Barton F. Haynes, Lindsey R. Baden, NIAID HVTN 133 Study Group
medRxiv 2024.03.15.24304305; doi: https://doi.org/10.1101/2024.03.15.24304305
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area